Abstract:In Type 1 and Type 2 diabetes, pancreatic β-cell survival and function are impaired. Additional etiologies of diabetes include dysfunction in insulin-sensing hepatic, muscle, and adipose tissues as well as immune cells. An important determinant of metabolic health across these various tissues is mitochondria function and structure. This review focuses on the role of mitochondria in diabetes pathogenesis, with a specific emphasis on pancreatic β-cells. These dynamic organelles are obligate for β-cell survival, function, replication, insulin production, and control over insulin release. Therefore, it is not surprising that mitochondria are severely defective in diabetic contexts. Mitochondrial dysfunction poses challenges to assess in cause-effect studies, prompting us to assemble and deliberate the evidence for mitochondria dysfunction as a cause or consequence of diabetes. Understanding the precise molecular mechanisms underlying mitochondrial dysfunction in diabetes and identifying therapeutic strategies to restore mitochondrial homeostasis and enhance β-cell function are active and expanding areas of research. In summary, this review examines the multidimensional role of mitochondria in diabetes, focusing on pancreatic β-cells and highlighting the significance of mitochondrial metabolism, bioenergetics, calcium, dynamics, and mitophagy in the pathophysiology of diabetes. We describe the effects of diabetes-related gluco/lipotoxic, oxidative and inflammation stress on β-cell mitochondria, as well as the role played by mitochondria on the pathologic outcomes of these stress paradigms. By examining these aspects, we provide updated insights and highlight areas where further research is required for a deeper molecular understanding of the role of mitochondria in β-cells and diabetes.

Pancreatic β‐cell apoptosis in type 2 diabetes is related to post‐translational modifications of p53 (Review)

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Research Progress on the Mechanism of Beta-Cell Apoptosis in Type 2 Diabetes Mellitus

Effect of P53 on Pancreatic Cancer-Glucose Tolerance Abnormalities by Regulating Transglutaminase 2 in Resistance to Glucose Metabolic Stress

[Molecular Mechanism of Beta Cell Apoptosis Induced by P58 in High Glucose Medium].

Pancreatic Beta-cell Dysfunction in Type 2 Diabetes

Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

Protective Role of PPARdelta in Lipoapoptosis of Pancreatic Β Cells.

Pancreatic β-Cells, Diabetes and Autophagy

Pancreatic -cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

Impact of apoptosis and oxidative stress on pancreatic beta cell pathophysiology in streptozotocin-induced Type 1 diabetes mellitus

Mitochondrial bioenergetics, metabolism, and beyond in pancreatic β-cells and diabetes

Metabolic Stress and Compromised Identity of Pancreatic Beta Cells

A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes

The mitochondrial enzyme pyruvate carboxylase restricts pancreatic β-cell senescence by blocking p53 activation

Β-Cell Apoptosis and Therapy Trend in Patients with Type 2 Diabetes

Pancreas Β Cell Regeneration and Type 1 Diabetes (Review)

Dichotomous role of pancreatic HUWE1/MULE/ARF-BP1 in modulating beta cell apoptosis in mice under physiological and genotoxic conditions